Literature DB >> 1119871

Carcinoembryonic antigen and prognosis in patients with colon cancer.

P Lo Gerfo, F P Herter.   

Abstract

One-hundred and fifty patients with non-metastatic colo-rectal cancer were followed for a period of 24 to 36 months postoperatively. Preoperative CEA values have been shown to correlate with the extent of the disease and the patient's prognosis. The prognosis for recurrences is greater in patients with elevated pre-operative CEA values regardless of the stage of their disease. This tendency to have recurrences is 1.8 times higher in individuals with increased pre-operative CEA levels. This same relationship occurs to a greater or lesser extent at each stage of the disease.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1119871      PMCID： PMC1343719          DOI： 10.1097/00000658-197501000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


  23 in total

1.  Immunologic tests for the detection of gastrointestinal cancers.

Authors:  P Lo Gerfo; F P Herter; H G Barker; S Bennett
Journal:  Surg Clin North Am       Date:  1972-08       Impact factor: 2.741

2.  Tumor associated antigen with pulmonary neoplasms.

Authors:  P Lo Gerfo; F P Herter; J Braun; H J Hansen
Journal:  Ann Surg       Date:  1972-04       Impact factor: 12.969

3.  Studies on tumor-associated antigen: TAA.

Authors:  P L Gerfo; F P Herter; V L Volsi; S Bennett
Journal:  J Surg Res       Date:  1973-10       Impact factor: 2.192

4.  Immunologic diagnosis and prognosis of human digestive-tract cancer: carcinoembryonic antigens.

Authors:  N Zamcheck; T L Moore; P Dhar; H Kupchik
Journal:  N Engl J Med       Date:  1972-01-13       Impact factor: 91.245

Review 5.  Tumors and serum glycoproteins. The 'symbodies'.

Authors:  C A Apffel; J H Peters
Journal:  Prog Exp Tumor Res       Date:  1969

6.  Tumor-associated (CEA-reacting) antigen in patients with inflammatory bowel disease.

Authors:  A H Rule; E Straus; J Vandevoorde; H D Janowitz
Journal:  N Engl J Med       Date:  1972-07-06       Impact factor: 91.245

7.  Carcinoembryonic antigen in patients with different cancers.

Authors:  G Reynoso; T M Chu; D Holyoke; E Cohen; T Nemoto; J J Wang; J Chuang; P Guinan; G P Murphy
Journal:  JAMA       Date:  1972-04-17       Impact factor: 56.272

8.  Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation.

Authors:  H Denk; G Tappeiner; R Eckerstorfer; J H Holzner
Journal:  Int J Cancer       Date:  1972-09-15       Impact factor: 7.396

9.  The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system.

Authors:  D M Thomson; J Krupey; S O Freedman; P Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

10.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307
View more
  11 in total

1.  Rectal adenocarcinoma: proposal for a model based on pretreatment prognostic factors.

Authors:  Fernando Cabanillas; Mariely Nieves-Plaza; Gerardo Quevedo; Ignacio A Echenique
Journal:  P R Health Sci J       Date:  2012-06       Impact factor: 0.705

2.  Clinical studies on carcinoembryonic antigen in pancreatic cancer.

Authors:  T Yamauchi; A Funakoshi; H Wakasugi; A Hayakawa; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1979

3.  The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials.

Authors:  N Wolmark; B Fisher; H S Wieand; R S Henry; H Lerner; S Legault-Poisson; P J Deckers; N Dimitrov; P H Gordon; P Jochimsen
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

4.  Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer.

Authors:  H F Sears; M Herlyn; B Del Villano; Z Steplewski; H Koprowski
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

5.  Immunoreactive carcinoembryonic antigen [CEA] levels in feces from colorectal cancer patients.

Authors:  Y Kitsukawa
Journal:  Jpn J Surg       Date:  1979-06

Review 6.  Carcinoembryonic antigen in patients with breast or colon cancer.

Authors:  Y N Lee
Journal:  West J Med       Date:  1978-11

7.  [Relapse prognosis for patients with adenocarcinoma of the gastrointestinal tract on the basis of carcinoembryonic antigen (CEA) and its circulating immune complexes (author's transl)].

Authors:  H J Staab; F A Anderer; E Stumpf; R Fischer
Journal:  Klin Wochenschr       Date:  1980-02-01

8.  [The significance of the preoperative CEA value for the prognosis of rectal cancer].

Authors:  B Mentges; R Brückner; C Weiss
Journal:  Langenbecks Arch Chir       Date:  1990

9.  [Effect of serial CEA determination on diagnosis, therapy and prognosis of recurrent colorectal cancer].

Authors:  B Mentges
Journal:  Langenbecks Arch Chir       Date:  1988

10.  The clinicopathologic features of serum CA 19-9-positive colorectal cancers.

Authors:  T Ueda; E Shimada; T Urakawa
Journal:  Surg Today       Date:  1994       Impact factor: 2.549
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.